Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels
- 30 September 1993
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 32 (9), 901-907
- https://doi.org/10.1016/0028-3908(93)90146-t
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Both splicing variants of the dopamine D2 receptor mRNA are up-regulated by antipsychotic drugsNeuroscience Letters, 1993
- Lack of effect of chronic antipsychotic treatment on dopamine D5 receptor mRNA levelEuropean Neuropsychopharmacology, 1992
- Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.Journal of Medical Genetics, 1992
- Distribution of D5 dopamine receptor mRNA in rat brainNeuroscience Letters, 1992
- Atypical antipsychotics elevate dopamine D3 but not D1 or D2 receptor mRNA levels in rat brainEuropean Neuropsychopharmacology, 1992
- Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatmentPsychopharmacology, 1992
- Clozapine: A Hypothesised Mechanism for its Unique Clinical ProfileThe British Journal of Psychiatry, 1992
- Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatmentPsychopharmacology, 1992
- The Mechanism of Action of Novel Antipsychotic DrugsSchizophrenia Bulletin, 1991
- The nucleotide sequence of the rat cytoplasmic β–actin geneNucleic Acids Research, 1983